Related Experiment Video
Updated: Aug 10, 2026
09:01
The Double-H Maze: A Robust Behavioral Test for Learning and Memory in Rodents
Published on: July 8, 2015
Approaches to memory loss in neuropsychiatric disorders
1New York Memory and Health Aging Services, Department of Medicine, Division of Neurology, Lenox Hill Hospital, 65 East 76th Street, New York, NY 10021, USA. Gd@nymemory.org
Seminars in Clinical Neuropsychiatry
|April 6, 2001
Summary
Neuropsychiatric disorders impact memory, involving key brain regions like the hippocampus and neurotransmitters. Treatments often model Alzheimer's dementia, focusing on cognitive function restoration.
Area of Science:
- Neuroscience
- Cognitive Science
- Neurology
Background:
- Memory is crucial for cognitive function and is impacted by numerous neuropsychiatric disorders.
- Specific brain regions, including the hippocampus and various cortical and thalamic areas, form the neuroanatomic basis of memory.
- Neurotransmitters and neuromodulators such as acetylcholine, dopamine, glutamate, GABA, catecholamines, and estrogen play vital roles in modulating cognitive processes.
Purpose of the Study:
- To review the neuroanatomical structures involved in memory.
- To discuss the role of neurotransmitters and neuromodulators in cognitive function.
- To outline current treatment strategies for memory loss, using Alzheimer's dementia as a primary model.
Main Methods:
- Literature review of neuroanatomy and neurochemistry related to memory.
- Analysis of established treatment paradigms for memory impairment.
- Discussion of therapeutic approaches based on neurobiological mechanisms.
Main Results:
- Identification of key brain regions (hippocampus, frontal, temporal, parietal cortices, thalamus) essential for memory.
- Confirmation of the modulatory effects of multiple neurotransmitters (acetylcholine, dopamine, glutamate, GABA, catecholamines) and estrogen on cognition.
- Established treatment approaches for memory loss are largely informed by Alzheimer's dementia research.
Conclusions:
- Memory function is supported by a complex network of brain regions and neurochemical systems.
- Understanding these systems is critical for developing effective interventions for memory disorders.
- Current therapeutic strategies for memory loss are predominantly based on the pathological framework of Alzheimer's dementia.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:13Amnesia
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...